Immuneering Corporation (IMRX)Healthcare | Biotechnology | Cambridge, United States | NasdaqGM
5.53 USD
-0.03
(-0.540%) ⇩
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 1:45 a.m. EDT
Despite analyst upgrades and significant positive trial data supporting 43% upside, the immediate market narrative is defensive. The company is booking put-heavy flow after news of the pancreatic drug's survival data, creating a short-term headwind. While the risk-reward profile looks attractive long-term given the cash-rich balance sheet and high valuation caps, the fundamental pressure from the recent data readout suggests a higher probability of a near-term pullback or consolidation prior to any upside move. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.049076 |
| AutoETS | 0.049365 |
| AutoARIMA | 0.049371 |
| MSTL | 0.057182 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.46 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.618 |
| Excess Kurtosis | -0.65 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.75 |
| Market Cap | 357,530,720 |
| Forward P/E | -4.09 |
| Beta | 0.43 |
| Website | https://immuneering.com |
As of April 19, 2026, 1:45 a.m. EDT: Options flow displays a distinct skew toward downside protection (puts). In the near term (May expiration), put volume at the ATM strike is heavily elevated compared to call volume at the same strike, with significant out-of-the-money (OTM) put open interest concentrated at higher strikes ($7.50, $10.00). This suggests speculators are positioning for a decline or protecting against a drop, potentially due to the recent reporting of survival data for their pancreatic cancer drug which may have exceeded expectations or introduced uncertainty. Conversely, calls show bullish positioning at OTM strikes ($10.00, $7.50), but the sheer volume of Puts dominates the 1-month and 2-month expirations.
| Attribute | Value |
|---|---|
| 52 Week Change | 3.0072465 |
| Address1 | 245 Main Street |
| Address2 | Second Floor |
| All Time High | 33.99 |
| All Time Low | 1.0 |
| Ask | 5.57 |
| Ask Size | 1 |
| Audit Risk | 7 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 815,510 |
| Average Daily Volume3 Month | 967,555 |
| Average Volume | 967,555 |
| Average Volume10Days | 815,510 |
| Beta | 0.427 |
| Bid | 5.48 |
| Bid Size | 1 |
| Board Risk | 6 |
| Book Value | 3.38 |
| City | Cambridge |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.53 |
| Current Ratio | 17.496 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 5.68 |
| Day Low | 5.2775 |
| Debt To Equity | 1.75 |
| Display Name | Immuneering |
| Earnings Call Timestamp End | 1,762,808,400 |
| Earnings Call Timestamp Start | 1,762,808,400 |
| Earnings Timestamp | 1,772,803,800 |
| Earnings Timestamp End | 1,778,011,200 |
| Earnings Timestamp Start | 1,778,011,200 |
| Ebitda | -59,022,184 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.194 |
| Enterprise Value | 188,523,840 |
| Eps Current Year | -1.18667 |
| Eps Forward | -1.35333 |
| Eps Trailing Twelve Months | -1.27 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.2074 |
| Fifty Day Average Change | 0.32260036 |
| Fifty Day Average Change Percent | 0.061950374 |
| Fifty Two Week Change Percent | 300.72464 |
| Fifty Two Week High | 10.08 |
| Fifty Two Week High Change | -4.5499997 |
| Fifty Two Week High Change Percent | -0.45138887 |
| Fifty Two Week Low | 1.1 |
| Fifty Two Week Low Change | 4.4300003 |
| Fifty Two Week Low Change Percent | 4.0272727 |
| Fifty Two Week Range | 1.1 - 10.08 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,627,651,800,000 |
| Float Shares | 49,398,715 |
| Forward Eps | -1.35333 |
| Forward P E | -4.086217 |
| Free Cashflow | -28,047,836 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 53 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.17826 |
| Held Percent Institutions | 0.50802 |
| Implied Shares Outstanding | 64,652,926 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-07-30 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Immuneering Corporation, a late-stage oncology company, develops medicines for broad populations of cancer patients in the United States. The company develops IMM-1-104 (atebimetinib), a dual-MEK inhibitor that is in a Phase 3 clinical trial to treat patients with cancer, including pancreatic and non-small cell lung cancer caused by mutations of RAS or RAF; IMM-6-415 (envometinib), which is in Phase 1/2a clinical trial for the treatment of patients with solid tumors; and multiple deep cyclic inhibitor discovery programs. The company has clinical supply agreements with Regeneron Pharmaceuticals to evaluate atebimetinib in combination with Libtayo in patients with unresectable or metastatic RAS-mutant non-small cell lung cancer; and with Eli Lilly and Company to evaluate atebimetinib in combination with olomorasib in patients with advanced or metastatic KRAS G12C-mutant non-small cell lung cancer. Immuneering Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts. |
| Long Name | Immuneering Corporation |
| Market | us_market |
| Market Cap | 357,530,720 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_308350677 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -56,024,896 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 357,530,680 |
| Number Of Analyst Opinions | 6 |
| Open | 5.635 |
| Operating Cashflow | -45,344,596 |
| Operating Margins | 0.0 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 617 500 8080 |
| Pre Market Change | -0.018900394 |
| Pre Market Change Percent | -0.34177926 |
| Pre Market Price | 5.5111 |
| Pre Market Time | 1,776,765,030 |
| Previous Close | 5.56 |
| Price Eps Current Year | -4.6600995 |
| Price Hint | 2 |
| Price To Book | 1.6360947 |
| Profit Margins | 0.0 |
| Quick Ratio | 17.157 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.2 |
| Region | US |
| Regular Market Change | -0.03 |
| Regular Market Change Percent | -0.539564 |
| Regular Market Day High | 5.68 |
| Regular Market Day Low | 5.2775 |
| Regular Market Day Range | 5.2775 - 5.68 |
| Regular Market Open | 5.635 |
| Regular Market Previous Close | 5.56 |
| Regular Market Price | 5.53 |
| Regular Market Time | 1,776,715,201 |
| Regular Market Volume | 709,427 |
| Return On Assets | -0.2607 |
| Return On Equity | -0.43118 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 64,652,926 |
| Shares Percent Shares Out | 0.1593 |
| Shares Short | 10,302,389 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 11,070,458 |
| Short Name | Immuneering Corporation |
| Short Percent Of Float | 0.1835 |
| Short Ratio | 9.2 |
| Source Interval | 15 |
| State | MA |
| Symbol | IMRX |
| Target High Price | 30.0 |
| Target Low Price | 11.0 |
| Target Mean Price | 17.0 |
| Target Median Price | 14.5 |
| Total Cash | 172,831,264 |
| Total Cash Per Share | 2.673 |
| Total Debt | 3,824,425 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.27 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.60165 |
| Two Hundred Day Average Change | -0.07165003 |
| Two Hundred Day Average Change Percent | -0.012790878 |
| Type Disp | Equity |
| Volume | 709,427 |
| Website | https://immuneering.com |
| Zip | 2,142 |